Vanguard Capital Management’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.8M Buy
488,805
+15,273
+3% +$449K ﹤0.01% 2545
2026
Q1
$14.6M Buy
+473,532
New +$11.7M ﹤0.01% 2515

Other funds holding TECX

Vanguard Capital Management's TECX Position: Q2 2026 in Review

Vanguard Capital Management increased its Tectonic Therapeutic (TECX) stake by 3.2% in Q2 2026, buying an estimated $449K and bringing the position to 488,805 shares worth $16.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2545.

Vanguard Capital Management first reported a position in TECX in Q1 2026 and has held it in 2 quarters since. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • Vanguard Capital Management held 488,805 shares of Tectonic Therapeutic worth $16.8M as of Q2 2026.
  • Vanguard Capital Management bought 15,273 Tectonic Therapeutic shares in Q2 2026, an estimated $449K.
  • Tectonic Therapeutic made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2545 holding.
  • Vanguard Capital Management first reported a position in Tectonic Therapeutic in Q1 2026 and has held it in 2 quarters since.
  • 123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.